{"url":"https://lda.senate.gov/api/v1/filings/b4d3766f-81c7-4ddc-a28e-dc1e618bf00a/","filing_uuid":"b4d3766f-81c7-4ddc-a28e-dc1e618bf00a","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2024,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/b4d3766f-81c7-4ddc-a28e-dc1e618bf00a/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matthew Wise","dt_posted":"2025-01-14T12:18:11-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Ave NW STE 979","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":401105210,"url":"https://lda.senate.gov/api/v1/registrants/401105210/","house_registrant_id":null,"name":"WISE CAPITAL STRATEGY, LLC","description":"strategic consulting","address_1":"300 New Jersey Ave NW STE 979","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATTHEW WISE","contact_telephone":"+1 202-360-9857","dt_updated":"2026-07-29T18:06:29.517417-04:00"},"client":{"id":61109,"url":"https://lda.senate.gov/api/v1/clients/61109/","client_id":61109,"name":"AMITY HOLDINGS LLC DBA PIP DIABETES CARE","general_description":"medical device supplier","client_government_entity":null,"client_self_select":false,"state":"TN","state_display":"Tennessee","country":"US","country_display":"United States of America","ppb_state":"TN","ppb_state_display":"Tennessee","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-07-10"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Healthcare and trade issues which may impact efforts to make diabetes care products more accessible.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70703,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"WISE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}